Cargando…

Longitudinal change in c-terminal fibroblast growth factor 23 and outcomes in patients with advanced chronic kidney disease

BACKGROUND: Fibroblast growth factor23 (FGF23) is elevated in CKD and has been associated with outcomes such as death, cardiovascular (CV) events and progression to Renal Replacement therapy (RRT). The majority of studies have been unable to account for change in FGF23 over time and those which have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alderson, Helen V., Chinnadurai, Rajkumar, Ibrahim, Sara T., Asar, Ozgur, Ritchie, James P., Middleton, Rachel, Larsson, Anders, Diggle, Peter J., Larsson, Tobias E., Kalra, Philip A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487581/ https://www.ncbi.nlm.nih.gov/pubmed/34600515 http://dx.doi.org/10.1186/s12882-021-02528-2

Ejemplares similares

The influence of multiple episodes of acute kidney injury on survival and progression to end stage kidney disease in patients with chronic kidney disease
por: Sykes, Lynne, et al.
Publicado: (2019)

Adverse outcomes associated with rapid linear and non-linear patterns of chronic kidney disease progression
por: Ali, Ibrahim, et al.
Publicado: (2021)

Predictive factors of rapid linear renal progression and mortality in patients with chronic kidney disease
por: Ali, Ibrahim, et al.
Publicado: (2020)

A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidism
por: Eddington, Helen, et al.
Publicado: (2021)

Kidney Transplant-Associated Viral Infection Rates and Outcomes in a Single-Centre Cohort
por: Pullerits, Kairi, et al.
Publicado: (2022)

Associations of urological malignancies with renal progression and mortality in advanced chronic kidney disease: a propensity-matched cohort study
por: Chinnadurai, Rajkumar, et al.
Publicado: (2020)

Decreased Concentration of Fibroblast Growth Factor 23 (FGF-23) as a Result of Supplementation with Selenium and Coenzyme Q(10) in an Elderly Swedish Population: A Sub-Analysis
por: Alehagen, Urban, et al.
Publicado: (2022)

New-Onset and Relapsed Kidney Histopathology Following COVID-19 Vaccination: A Systematic Review
por: Wu, Henry H. L., et al.
Publicado: (2021)

A Paradigm to Discover Biomarkers Associated With Chronic Kidney Disease Progression
por: Ali, Ibrahim, et al.
Publicado: (2020)

Extreme Elevations in Blood Pressure and All-Cause Mortality in a Referred CKD Population: Results from the CRISIS Study
por: Ritchie, James, et al.
Publicado: (2013)

Cancer patterns and association with mortality and renal outcomes in non-dialysis dependent chronic kidney disease: a matched cohort study
por: Chinnadurai, Rajkumar, et al.
Publicado: (2019)

Distribution and association of cancer with mortality in end-stage renal disease patients receiving dialysis
por: Chinnadurai, Rajkumar, et al.
Publicado: (2019)

The role of patiromer: Comparing OPAL-HK data with untreated real-world patients in the United Kingdom—A retrospective, propensity-matched analysis
por: Ali, Ibrahim, et al.
Publicado: (2020)

Physiologically‐Based Pharmacokinetic Modelling of Creatinine‐Drug Interactions in the Chronic Kidney Disease Population
por: Takita, Hiroyuki, et al.
Publicado: (2020)

Calciphylaxis in end-stage kidney disease: outcome data from the United Kingdom Calciphylaxis Study
por: Chinnadurai, Rajkumar, et al.
Publicado: (2021)

Intrinsic Kidney Pathology Following COVID-19 Infection in Children and Adolescents: A Systematic Review
por: Wu, Henry H. L., et al.
Publicado: (2021)

Intrinsic Kidney Pathology in Children and Adolescents Following COVID-19 Vaccination: A Systematic Review
por: Wu, Henry H. L., et al.
Publicado: (2022)

Impact of prior stroke on major clinical outcome in chronic kidney disease: the Salford kidney cohort study
por: Tollitt, James, et al.
Publicado: (2019)

Revascularization as a treatment to improve renal function
por: Alderson, Helen V, et al.
Publicado: (2014)

Treatment of anaemia in end-stage renal disease: A double-edged iron sword?
por: Chinnadurai, Rajkumar, et al.
Publicado: (2019)

The epidemiology and evolution of IgA nephropathy over two decades: A single centre experience
por: Storrar, Joshua, et al.
Publicado: (2022)

Obesity and chronic kidney disease: A current review
por: Nawaz, Saira, et al.
Publicado: (2022)

A low rate of end-stage kidney disease in membranous nephropathy: A single centre study over 2 decades
por: Storrar, Joshua, et al.
Publicado: (2022)

Fibroblast growth factor 23, mineral metabolism and mortality among elderly men (Swedish MrOs)
por: Westerberg, Per-Anton, et al.
Publicado: (2013)

COVID-19 and hepatorenal syndrome
por: Wu, Henry H L, et al.
Publicado: (2022)

Genetic polymorphism in C3 is associated with progression in chronic kidney disease (CKD) patients with IgA nephropathy but not in other causes of CKD
por: Ibrahim, Sara T., et al.
Publicado: (2020)

Predictors of intact and C-terminal fibroblast growth factor 23 in Gambian children
por: Braithwaite, Vickie, et al.
Publicado: (2013)

Fibroblast-growth factor 23 promotes terminal differentiation of ATDC5 cells
por: Guibert, Mathilde, et al.
Publicado: (2017)

Association between non-malignant monoclonal gammopathy and adverse outcomes in chronic kidney disease: A cohort study
por: Fenton, Anthony, et al.
Publicado: (2020)

COVID-19 in Elderly Patients Receiving Haemodialysis: A Current Review
por: McDonnell, Thomas, et al.
Publicado: (2023)

Native and transplant kidney histopathological manifestations in association with COVID-19 infection: A systematic review
por: Jeyalan, Vishnu, et al.
Publicado: (2021)

Improving outpatient clinic experience: the future of chronic kidney disease care and associated multimorbidity
por: Al-Chalabi, Saif, et al.
Publicado: (2023)

Epoetin Beta and C‐Terminal Fibroblast Growth Factor 23 in Patients With Chronic Heart Failure and Chronic Kidney Disease
por: Eisenga, Michele F., et al.
Publicado: (2019)

Using Prior Knowledge on Systems Through PBPK to Gain Further Insight into Routine Clinical Data on Trough Concentrations: The Case of Tacrolimus in Chronic Kidney Disease
por: El-Khateeb, Eman, et al.
Publicado: (2023)

Longitudinal trends in laboratory test utilization at a large tertiary care university hospital in Sweden
por: Mindemark, Mirja, et al.
Publicado: (2011)

Non-invasive cardiac stress studies may not offer significant benefit in pre-kidney transplant evaluation: A retrospective cohort study
por: Kanigicherla, Durga Anil K., et al.
Publicado: (2020)

Does previous stroke modify the relationship between inflammatory biomarkers and clinical endpoints in CKD patients?
por: Tollitt, James, et al.
Publicado: (2022)

The Role of Iron in Calciphylaxis—A Current Review
por: Wickens, Olivia, et al.
Publicado: (2022)

Longitudinal effects of aging on plasma proteins levels in older adults – associations with kidney function and hemoglobin levels
por: Lind, Lars, et al.
Publicado: (2019)

Web‐based integrated bipolar parenting intervention for parents with bipolar disorder: a randomised controlled pilot trial
por: Jones, Steven H., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dtpvivalhr9pvaee85hn2h34ci